Transforming Health Care Through Evidence and Collaboration
Transforming Health Care Through Evidence and Collaboration

Featured

During this webinar, panelists discussed opportunities and challenges in the generic and biosimilar market, how past administrations have approached this issue, and the impact on different stakeholders, including consumers.

Alliance-June-Webinar-Image
ShareThis

Will Washington Finally Act on Drug Prices?

November 26, 2019 | 02:00 PM
03:00 PM ET

Lowering prescription drug prices remains a high priority for voters of all party affiliations. Members in the U.S. House of Representatives and the Senate have drafted legislation to address high drug prices, and the House is expected to vote on a drug pricing bill tomorrow - but do these bills have a chance of passing into law?

Part of the Health Matters webinar series, this webinar provided an update on federal and state policy efforts to lower drug prices, including:

  • An overview of the pharmaceutical industry and opportunities for cost savings
  • State strategies to lower drug prices, including transparency laws and affordability reviews
  • Insights on the leading policy proposals in Congress and the Trump Administration and potential barriers to their success

This webinar is a project of the USC Annenberg Center for Health Journalism and NIHCM Foundation.

Learn More

Speakers

soodneeraj-full-500x500
Neeraj Sood
University of Southern California
lynn-quincy-467x467
Lynn Quincy
Altarum Institute
levfacher24-512x512
Lev Facher
STAT News